Page last updated: 2024-08-24

dexmedetomidine and Debility

dexmedetomidine has been researched along with Debility in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Busund, R; Haaverstad, R; Helbostad, JL; Landsverk, SA; Martinaityte, I; Neerland, BE; Norum, HM; Ræder, J; Selbaek, G; Simpson, MR; Skaar, E; Skjærvold, NK; Skovlund, E; Slooter, AJ; Svendsen, ØS; Tønnessen, T; Wahba, A; Wyller, TB; Zetterberg, H	1

Trials

1 trial(s) available for dexmedetomidine and Debility

Article	Year
Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial. BMJ open, 2022, 06-20, Volume: 12, Issue:6 Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Cardiac Surgical Procedures; Clonidine; Cognitive Dysfunction; Delirium; Dexmedetomidine; Double-Blind Method; Frailty; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic	2022

Article

Year

Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial.

BMJ open, 2022, 06-20, Volume: 12, Issue:6

Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Cardiac Surgical Procedures; Clonidine; Cognitive Dysfunction; Delirium; Dexmedetomidine; Double-Blind Method; Frailty; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic

2022